Hypothalamic insulin signaling is required for inhibition of glucose production
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Circulating insulin inhibits endogenous glucose production. Here we report that bidirectional changes in hypothalamic insulin signaling affect glucose production. The infusion of either insulin or a small-molecule insulin mimetic in the third cerebral ventricle suppressed glucose production independent of circulating levels of insulin and of other glucoregulatory hormones. Conversely, central antagonism of insulin signaling impaired the ability of circulating insulin to inhibit glucose production. Finally, third-cerebral-ventricle administration of inhibitors of ATP-sensitive potassium channels, but not of antagonists of the central melanocortin receptors, also blunted the effect of hyperinsulinemia on glucose production. These results reveal a new site of action of insulin on glucose production and suggest that hypothalamic insulin resistance can contribute to hyperglycemia in type 2 diabetes mellitus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both, peripheral and central insulin signaling are impaired in obese or diabetic states.150, 151, 152, 153, 154”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [153]
In the citing paper
“these effects of insulin are blocked by infusion of the PI3K inhibitor and also appear to require activation of KATP channels (135, 145).”
From Leptin and the Central Nervous System Control of Glucose Metabolism (2011) · cites this paper as [135]
In the citing paper
“administration of insulin into either the third ventricle or the mediobasal hypothalamus improves insulin sensitivity via enhanced suppression of hepatic glucose production, with no effect on glucose uptake (135).”
From Leptin and the Central Nervous System Control of Glucose Metabolism (2011) · cites this paper as [135]
In the citing paper
“Although accumulating evidence suggests that leptin (10 -13), insulin (14,15), and nutrient-related signals (16 -18) in the CNS improve hepatic insulin sensitivity”
From Leptin Activates a Novel CNS Mechanism for Insulin-Independent Normalization of Severe Diabetic Hyperglycemia (2011) · cites this paper as [14]
In the citing paper
“Several lines of evidence suggest that like leptin, insulin action in the brain of nondiabetic animals lowers ambient glycemia by increasing hepatic insulin sensitivity (14,15).”
From Leptin Activates a Novel CNS Mechanism for Insulin-Independent Normalization of Severe Diabetic Hyperglycemia (2011) · cites this paper as [14]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,705
Self-citationRole of Brain Insulin Receptor in Control of Body Weight and Reproduction
Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235
Role of melanocortinergic neurons in feeding and the agouti obesity syndrome
Fan, W., Boston, B. A., Kesterson, R. A., Hruby, V. J., & Cone, R. D. (1997) · Nature · doi:10.1038/385165a0 · Cited by 1,902 · cited 1×
“As a similar experimental approach blocks the effects of leptin and melanocortins on food intak”
ResultIsolated removal of hypothalamic or other brain nuclei of the rat
Palkovits, M. (1973) · Brain Research · doi:10.1016/0006-8993(73)90290-4 · Cited by 1,431 · cited 1×
“version of a method originally described by Palkovit”
MethodSignals That Regulate Food Intake and Energy Homeostasis
Woods, S. C., Seeley, R. J., Porte, D., & Schwartz, M. W. (1998) · Science · doi:10.1126/science.280.5368.1378 · Cited by 1,169
Effect of Insulin and Glucose Infusions on Sympathetic Nervous System Activity in Normal Man
Rowe, J. W., Young, J. B., Minaker, K. L., Stevens, A. L., Pallotta, J., & Landsberg, L. (1981) · Diabetes · doi:10.2337/diab.30.3.219 · Cited by 1,143
Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons
Woods, S. C., Lotter, E. C., McKay, L. D., & Porte, D. (1979) · Nature · doi:10.1038/282503a0 · Cited by 1,114
Rossetti, L., Smith, D., Shulman, G. I., Papachristou, D., & DeFronzo, R. A. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112981 · Cited by 809
Self-citationInsulin in the Brain: A Hormonal Regulator of Energy Balance*
SCHWARTZ, M. W., FIGLEWICZ, D. P., BASKIN, D. G., WOODS, S. C., & PORTE, D. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-3-387 · Cited by 807
Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats
Obici, S., Feng, Z., Karkanias, G., Baskin, D. G., & Rossetti, L. (2002) · Nature Neuroscience · doi:10.1038/nn0602-861 · Cited by 719
Self-citation
Research works printed but not linked: 1
- Hopkins, D.F. & Williams, G. Insulin receptors are widely distributed in human brain and bind human and porcine insulin with equal affinity. Diabet. Med. 14, 1044–1050 (1997). · doi:10.1002/(sici)1096-9136(199712)14:12<1044::aid-dia508>3.0.co;2-f
Cited by
Items 201–300 of 939
Heni, M., Wagner, R., Kullmann, S., Gancheva, S., Roden, M., Peter, A., Stefan, N., Preissl, H., Häring, H.-U., & Fritsche, A. (2017) · Diabetes · doi:10.2337/db16-1380 · Cited by 115
“In line with rodent data at fasting insulin levels (12), the study by Dash et al.”
ResultThe effects of type 1 diabetes on the hypothalamic, pituitary and testes axis
Schoeller, E. L., Schon, S. B., & Moley, K. H. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1387-7 · Cited by 121
“This study further demonstrates that neuronal insulin action is regulated separately from plasma insulin and might be involved in overall energy homeostasis mediated by the central nervous system (Obici et al. 2002).”
Heni, M., Kullmann, S., Ketterer, C., Guthoff, M., Linder, K., Wagner, R. J., Stingl, K. T., Veit, R., Staiger, H., Häring, H., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2528-y · Cited by 119
“This enhancement may occur mainly in the classical insulinsensitive tissues liver [6], adipocytes [7] and muscle [8], as suggested by animal studies.”
BackgroundResultInsulin Activates Erk1/2 Signaling in the Dorsal Vagal Complex to Inhibit Glucose Production
Filippi, B., Yang, C. S., Tang, C., & Lam, T. K. T. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.09.005 · Cited by 114
Binge Drinking Induces Whole-Body Insulin Resistance by Impairing Hypothalamic Insulin Action
Lindtner, C., Scherer, T., Zielinski, E., Filatova, N., Fasshauer, M., Tonks, N. K., Puchowicz, M., & Buettner, C. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005123 · Cited by 112
“In addition, insulin controls autonomic nervous system outflow to the liver (10) and adipose tissue (11) through signaling in the central nervous system, thereby restraining hGP and fatty acid release.”
InfluentialHallschmid, M. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.12934 · Cited by 113
Ceccarelli, S. M., Chomienne, O., Gubler, M., & Arduini, A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100809g · Cited by 119
Zhang, R., Dhillon, H., Yin, H., Yoshimura, A., Lowell, B. B., Maratos-Flier, E., & Flier, J. S. (2008) · Endocrinology · doi:10.1210/en.2008-0805 · Cited by 106
Brain insulin and feeding: a bi-directional communication
Gerozissis, K. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.044 · Cited by 134
Tsaousidou, E., Paeger, L., Belgardt, B., Pál, M., Wunderlich, C. M., Brönneke, H. S., Collienne, U., Hampel, B., Wunderlich, F. T., Schmidt‐Supprian, M., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.045 · Cited by 119
Prediabetes Is Associated With Structural Brain Abnormalities: The Maastricht Study
van Agtmaal, M. J. M., Houben, A. J. H. M., de Wit‐Verheggen, V. H. W., Henry, R. M. A., Schaper, N. C., Dagnelie, P. C., Kallen, C., Koster, A., Sep, S. J. S., Kroon, A. A., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1132 · Cited by 117
Glucose homeostasis, obesity and diabetes
Bano, G. (2013) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2013.02.007 · Cited by 131
Role of KLF15 in Regulation of Hepatic Gluconeogenesis and Metformin Action
Takashima, M., Ogawa, W., Hayashi, K., Inoue, H., Kinoshita, S., Okamoto, Y., Sakaue, H., Wataoka, Y., Emi, A., Senga, Y., et al. (2010) · Diabetes · doi:10.2337/db09-1679 · Cited by 115
“The clamp was maintained for 4 h, and hepatic glucose production (HGP) during the clamp was determined as described (18,19).”
MethodA Role for Insulin in Diabetic Neuropathy
Grote, C. W., & Wright, D. E. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00581 · Cited by 115
Striatal dopamine regulates systemic glucose metabolism in humans and mice
ter Horst, K. W., Lammers, N. M., Trinko, R., Opland, D. M., Figee, M., Ackermans, M. T., Booij, J., van den Munckhof, P., Schuurman, P. R., Fliers, E., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar3752 · Cited by 114
Bernal‐Mizrachi, C., Xiaozhong, L., Li, Y., Knutsen, R. H., Howard, M. J., Arends, J. J. A., DeSantis, P., Coleman, T., & Semenkovich, C. F. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2006.12.010 · Cited by 115
“Rossetti and colleagues recently provided evidence for links between the central nervous system and hepatic glucose production (Obici et al., 2002) involving the hepatic branch of the Cell Metab.”
BackgroundSartorius, T., Peter, A., Schulz, N., Drescher, A., Bergheim, I., Machann, J., Schick, F., Siegel-Axel, D. I., Schürmann, A., Weigert, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092358 · Cited by 115
Ruiz, H. H., Chi, T., Shin, A. C., Lindtner, C., Hsieh, W., Ehrlich, M., Gandy, S., & Buettner, C. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.01.008 · Cited by 105
“We propose that the brain amyloid pathology causes this disturbance in hypothalamic insulin signaling, and that the glucose intolerance (at least in this AD model) occurs as a result of impaired hypothalamic insulin action given its important role in controlling hepatic glucose metabolism [14].”
Backgroundvan den Hoek, A. M., Voshol, P. J., Karnekamp, B. N., Buijs, R. M., Romijn, J. A., Havekes, L. M., & Pijl, H. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2529 · Cited by 109
“Indeed, intracerebroventricular (ICV) infusion of insulin can suppress glucose production (by 40%) in the presence of basal circulating insulin concentrations, whereas antagonism of insulin signaling or downregulation of insulin receptor expression in hypothalamic nuclei considerably impairs the ability of circulating…”
BackgroundInfluentialBrain expression of Cre recombinase driven by pancreas‐specific promoters
Song, J., Xu, Y., Hu, X., Choi, B. J., & Tong, Q. (2010) · genesis · doi:10.1002/dvg.20672 · Cited by 109
Molecular Characterization of Insulin-Mediated Suppression of Hepatic Glucose Production In Vivo
Ramnanan, C. J., Edgerton, D. S., Rivera, N., Irimia-Dominguez, J., Farmer, B., Neal, D. W., Lautz, M., Donahue, E. P., Meyer, C. M., Roach, P. J., et al. (2010) · Diabetes · doi:10.2337/db09-1625 · Cited by 106
“Based on recent rodent studies it was concluded that hyperinsulinemia in the brain inhibited HGP by reducing gluconeogenesis associated with inhibition of GNG gene expression (13-15) and STAT3 phosphorylation (13).”
BackgroundCentral GLP-2 Enhances Hepatic Insulin Sensitivity via Activating PI3K Signaling in POMC Neurons
Shi, X., Zhou, F., Li, X., Chang, B. H.-J., Li, D., Wang, Y., Tong, Q., Xu, Y., Fukuda, M., Zhao, J. J., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.014 · Cited by 110
“Direct action of insulin and leptin on POMC neurons is required to maintain glucose homeostasis (Hill et al., 2010; Obici et al., 2002).”
BackgroundDash, S., Xiao, C., Morgantini, C., Koulajian, K., & Lewis, G. F. (2015) · Diabetes · doi:10.2337/db14-0685 · Cited by 108
“This is based on the previous findings that 1) INI increases CSF insulin concentration (12) and 2) intracerebroventricular insulin injection reduces the expression of gluconeogenic enzymes and HGP in rodents, an effect abrogated by resection of hepatic vagal efferents (5,6).”
BackgroundMethodResultInfluentialMechanism of ER Stress and Inflammation for Hepatic Insulin Resistance in Obesity
Kim, O., Jun, W., & Lee, J. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000440905 · Cited by 115
Brown, J. A., Woodworth, H. L., & Leinninger, G. M. (2015) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2015.00009 · Cited by 113
“, 1991), where it acts to suppress feeding, hepatic glucose production and to promote weight loss (Woods et al., 1979; Obici et al., 2002).”
BackgroundSOCS3 as a future target to treat metabolic disorders
Pedroso, J. A. B., Ramos-Lobo, A. M., & Donato, J. (2018) · HORMONES · doi:10.1007/s42000-018-0078-5 · Cited by 109
van Nimwegen, L. J. M., Storosum, J. G., Blümer, R. M. E., Allick, G., Venema, H. W., de Haan, L., Becker, H. E., van Amelsvoort, T., Ackermans, M. T., Fliers, E., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1167 · Cited by 106
SH2B1 regulation of energy balance, body weight, and glucose metabolism
Rui, L. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i4.511 · Cited by 112
Mayer, C., & Belsham, D. D. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.02.031 · Cited by 113
“Along with regulating feeding, entral insulin administration also decreases hepatic glucose outut (Obici et al., 2002).”
BackgroundTargeting the CNS to treat type 2 diabetes
Sandoval, D. A., Obici, S., & Seeley, R. J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2874 · Cited by 110
Self-citationHypothalamic Control of Systemic Glucose Homeostasis: The Pancreas Connection
Pozo, M., & Claret, M. (2018) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2018.05.001 · Cited by 106
The circadian system and the balance of the autonomic nervous system
Buijs, R. M., Escobar, C., & Swaab, D. F. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53491-0.00015-8 · Cited by 114
“…the above summary of hypothalamic integration, there is a wealth of experimental data from animals obtained on the role of the ARC in monitoring the composition of the blood for metabolic substances such as, e.g., insulin, glucose, ghrelin, and leptin (Obici et al., 2002a, b, 2003; Horvath, 2005).”
BackgroundHypothalamic Insulin Resistance in Obesity: Effects on Glucose Homeostasis
Chen, W., Balland, É., & Cowley, M. A. (2017) · Neuroendocrinology · doi:10.1159/000455865 · Cited by 110
Schizophrenia: a disorder of broken brain bioenergetics
Henkel, N., Wu, X., O'Donovan, S. M., Devine, E. A., Jiron, J. M., Rowland, L. M., Sarnyai, Z., Ramsey, A. J., Wen, Z., Hahn, M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01494-x · Cited by 107
Fructose-mediated stress signaling in the liver: implications for hepatic insulin resistance
Wei, Y., Wang, D., Topczewski, F., & Pagliassotti, M. J. (2006) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.03.013 · Cited by 125
“[41] Obici S, Zhang BB, Karkanias G, Rossetti L.”
BackgroundLiu, C., Fonken, L. K., Wang, A., Maiseyeu, A., Bai, Y., Wang, T.-Y., Maurya, S. K., Ko, Y.-A., Periasamy, M., Dvonch, T. J., et al. (2014) · Particle and Fibre Toxicology · doi:10.1186/s12989-014-0053-5 · Cited by 104
“As alterations in hypothalamic signaling induced by overnutrition (particularly hypothalamic leptin resistance) has been demonstrated to alter sympathetic outflow, this mechanism could also help couple sympathetic activation with systemic IR [44-46].”
Influence of Insulin in the Ventromedial Hypothalamus on Pancreatic Glucagon Secretion In Vivo
Paranjape, S. A., Chan, O., Zhu, W., Horblitt, A. M., McNay, E. C., Cresswell, J. A., Bogan, J. S., McCrimmon, R. J., & Sherwin, R. S. (2010) · Diabetes · doi:10.2337/db10-0014 · Cited by 94
“In addition, previous studies have demonstrated that delivery of insulin into the hypothalamus directly suppresses hepatic glucose production (16).”
BackgroundMultiorgan insulin sensitivity in lean and obese subjects
Conte, C., Fabbrini, E., Kars, M., Mittendorfer, B., Patterson, B. W., & Klein, S. (2012) · Diabetes Care · doi:10.2337/dc11-1951 · Cited by 99
“Furthermore, the extrahepatic effects of systemic insulin can decrease hepatic glucose production by suppressing adipose tissue lipolysis and circulating FFA (17), stimulating hypothalamic pathways (18), and inhibiting pancreatic glucagon secretion (19).”
BackgroundReno, C. M., Puente, E. C., Sheng, Z., Daphna-Iken, D., Bree, A. J., Routh, V. H., Kahn, B. B., & Fisher, S. J. (2016) · Diabetes · doi:10.2337/db16-0917 · Cited by 106
“Central insulin signaling may suppress EGP indirectly, possibly via efferent vagal and sympathetic actions (31,32).”
BackgroundBrain–gut–adipose-tissue communication pathways at a glance
Yi, C.-X., & Tschöp, M. H. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.009902 · Cited by 92
“…and the ARC in the forebrain are two of the major targets of gut hormones; insulin, produced in the pancreas, and ghrelin, produced in the stomach, are among the best studied gut hormones acting in these brain areas (Kojima et al., 1999; Obici et al., 2002; Pocai et al., 2005; Tschöp et al., 2000).”
BackgroundInfluentialGaspar, J. M., & Velloso, L. A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00813 · Cited by 108
New Twist on Neuronal Insulin Receptor Signaling in Health, Disease, and Therapeutics
Wada, A., Yokoo, H., Yanagita, T., & Kobayashi, H. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.crj05006x · Cited by 110
Ghrelin and lipid metabolism: key partners in energy balance
Varela, L., Vazquez, M. J., Cordido, F., Nogueiras, R., Vidal‐Puig, A., Diéguez, C., & López, M. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-10-0068 · Cited by 107
“…or a common mechanism for hormonal signals modulating both processes, such as leptin (Pocai et al. 2005b, Buettner et al. 2006, 2008), insulin (Obici et al. 2002a,b, Pocai et al. 2005a, Plum et al. 2006, Koch et al. 2008), melanocortins (Nogueiras et al. 2007), RSTN (Vázquez et al. 2008),…”
Ramnanan, C. J., Saraswathi, V., Smith, M. S., Donahue, E. P., Farmer, B., Farmer, T. D., Neal, D. W., Williams, P. E., Lautz, M., Mari, A., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45472 · Cited by 96
Increased Aβ production prompts the onset of glucose intolerance and insulin resistance
Jiménez-Palomares, M., Ramos‐Rodríguez, J. J., López-Acosta, J. F., Pacheco‐Herrero, M., Lechuga-Sancho, A. M., Perdomo, G., García-Alloza, M., & Cózar‐Castellano, I. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00500.2011 · Cited by 95
“(13), which demonstrated that disruption of hypothalamic insulin signaling impaired the ability of circulating insulin to inhibit glucose production, suggesting that hypothalamic insulin resistance can contribute to hyperglycemia in T2D.”
BackgroundZhang, Q., Pan, Y., Wang, R., Kang, L.-L., Xue, Q., Wang, X., & Kong, L. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.11.014 · Cited by 97
“Hypothalamic insulin signaling controls whole-body insulin sensitivity and lipid metabolism [4–7].”
BackgroundChang, C., Yeh, S., Lee, S. O., & Chang, T. (2013) · Nuclear Receptor Signaling · doi:10.1621/nrs.11001 · Cited by 98
“Hypothalamic insulin signaling is known to suppress hepatic glucose production [Obici et al., 2002; Pocai et al., 2005] through suppression of agouti related peptide (AgRP) release from hypothalamic arcuate nucleus [Konner et al., 2007].”
BackgroundShpakov, A. O., Derkach, K. V., & Berstein, L. M. (2015) · Future Science OA · doi:10.4155/fso.15.23 · Cited by 99
Vikram, A., & Jena, G. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.06.070 · Cited by 99
Effects of Insulin on the Metabolic Control of Hepatic Gluconeogenesis In Vivo
Edgerton, D. S., Ramnanan, C. J., Grueter, C. A., Johnson, K., Lautz, M., Neal, D. W., Williams, P. E., & Cherrington, A. D. (2009) · Diabetes · doi:10.2337/db09-0328 · Cited by 103
“It is postulated that brain insulin action increases vagal transmission, thereby increasing the phosphorylation of STAT3 in the liver and in turn reducing PEPCK and glucose-6-phosphatase (G6Pase) transcription (12-14).”
BackgroundAdiponectin Resistance Exacerbates Insulin Resistance in Insulin Receptor Transgenic/Knockout Mice
Lin, H. V., Kim, J., Pocai, A., Rossetti, L., Shapiro, L. S., Scherer, P. E., & Accili, D. (2007) · Diabetes · doi:10.2337/db07-0127 · Cited by 96
“Multiple mechanisms have been proposed to account for insulin’s indirect effects on HGP, including glucagon (10,11), gluconeogenic substrates released from muscle (12) and fat (13), and hypothalamic signals (9,14).”
BackgroundSelf-citationVisser, L., Zuurbier, C. J., Hoek, F. J., Opmeer, B. C., de Jonge, E., de Mol, B. A. J. M., & van Wezel, H. B. (2005) · British Journal of Anaesthesia · doi:10.1093/bja/aei220 · Cited by 92
Hypothalamic inflammation in metabolic disorders and aging
Bhusal, A., Rahman, M. H., & Suk, K. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04019-x · Cited by 94
“The exogenous administration of insulin in the brain might act on these receptors and reduce food intake, body weight [156], and endogenous glucose production [157].”
BackgroundGut–Brain Axis: Regulation of Glucose Metabolism
Heijboer, A. C., Pijl, H., van den Hoek, A. M., Havekes, L. M., Romijn, J. A., & Corssmit, E. P. M. (2006) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2006.01492.x · Cited by 101
Hallschmid, M., & Schultes, B. (2009) · Diabetologia · doi:10.1007/s00125-009-1501-x · Cited by 101
“Likewise, boosting hypothalamic insulin signalling may help normalise dysregulated hepatic gluconeogenesis [7], a hallmark of type 2 diabetes and peripheral insulin resistance [34], which appears to be highly associated with central nervous insulin resistance [39].”
BackgroundHirahatake, K. M., Slavin, J. L., Maki, K. C., & Adams, S. H. (2014) · Metabolism · doi:10.1016/j.metabol.2014.02.009 · Cited by 86
“[95] Obici S, Zhang BB, Karkanias G, et al.”
The endothelial cell: An “early responder” in the development of insulin resistance
Barrett, E. J., & Liu, Z. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-012-9232-6 · Cited by 88
“Recent studies have suggested a very important role for insulin acting at hypothalamic nuclei in the control of hepatic glucose output [70] and of lipolysis in adipose tissue [19].”
Hill, J. W., Xu, Y., Preitner, F., Fukuda, M., Cho, Y.-R., Luo, J., Balthasar, N., Coppari, R., Cantley, L. C., Kahn, B. B., et al. (2009) · Endocrinology · doi:10.1210/en.2009-0454 · Cited by 93
“Moreover, PI3K signaling in POMC neurons has the ability to influence body weight regulation, especially in response to a high-fat dietary challenge. and 0 5 10 15 20 25 * * Control pik3r1 POMCKO Basal HGP (mg/kg.min) 0 20 40 60 80 100 * Control pi3kr1 POMCKO HGP suppression (% of basal) A 0 20 40 60 80 Control pik3r1…”
BackgroundInfluentialImpaired peripheral glucose homeostasis and Alzheimer's disease
Wijesekara, N., Gonçalves, R. A., De Felice, F. G., & Fraser, P. E. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.027 · Cited by 80
Minireview: The Brain as a Molecular Target for Diabetic Therapy
Prodi, E., & Obici, S. (2006) · Endocrinology · doi:10.1210/en.2006-0143 · Cited by 88
Self-citationKimura, K., Yamada, T., Matsumoto, M., Kido, Y., Hosooka, T., Asahara, S., Matsuda, T., Ota, T., Watanabe, H., Sai, Y., et al. (2011) · Diabetes · doi:10.2337/db10-1684 · Cited by 94
“We have also demonstrated that activation of hepatic STAT3 is induced in an interleukin (IL)-6–dependent manner by braininsulin action, which is known to indirectly regulate hepatic gluconeogenic gene expression (8,9).”
BackgroundThe metabolic costs of cognition
Jamadar, S. D., Behler, A., Deery, H. A., & Breakspear, M. J. (2025) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2024.11.010 · Cited by 105
Maddux, B. A., Chang, Y.-N., Accili, D., McGuinness, O. P., YOUNGREN, J. F., & Goldfine, I. D. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00298.2005 · Cited by 88
“Although responsive to insulin in selected regions (21), generally the brain glucose uptake is unresponsive to insulin.”
Shimizu, H., Inoue, K., & Mori, M. (2007) · Journal of Endocrinology · doi:10.1677/joe-06-0144 · Cited by 99
“The hypothalamus also plays a pivotal role in organizing glucose output from the liver (Obici et al. 2002), in which glucose metabolism is mediated by leptin through activation on the central nervous system (Kamohara et al. 1997).”
BackgroundMicroglia activation due to obesity programs metabolic failure leading to type two diabetes
Maldonado-Ruiz, R., Montalvo-Martínez, L., Fuentes-Mera, L., & Camacho, A. (2017) · Nutrition & Diabetes · doi:10.1038/nutd.2017.10 · Cited by 86
Hypothalamic AMP-Activated Protein Kinase Regulates Glucose Production
Yang, C. S., Lam, C. K. L., Chari, M., Cheung, G. W. C., Kokorovic, A., Gao, S., Leclerc, I., Rutter, G. A., & Lam, T. K. T. (2010) · Diabetes · doi:10.2337/db10-0221 · Cited by 86
Bedinger, D., & Adams, S. H. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.08.013 · Cited by 94
Fasting‐Induced Activation of Mitogen‐Activated Protein Kinases (ERK/p38) in the Mouse Hypothalamus
Morikawa, Y., Ueyama, E., & Senba, E. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.0953-8194.2004.01135.x · Cited by 94
Antipsychotics and glucose metabolism: how brain and body collide
Kowalchuk, C., Castellani, L. N., Chintoh, A., Remington, G., Giacca, A., & Hahn, M. K. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00164.2018 · Cited by 85
“In rats, possibly owing to more rapid metabolism compared with humans (58), a 210-min central infusion of insulin is sufficient to induce suppression of hepatic glucose production (74), with our own data suggesting an observable effect as early as 150 min into the central infusion (62).”
BackgroundCotero, V. E., Graf, J. F., Miwa, H., Hirschstein, Z., Qanud, K., Huerta, T. S., Tai, N., Ding, Y., Jimenez-Cowell, K., Tomaio, J. N., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00870-w · Cited by 87
Insulin resistance as the molecular link between diabetes and Alzheimer's disease
Abdalla, M. M. I. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i7.1430 · Cited by 88
Lipid Sensing and Insulin Resistance in the Brain
Yue, J. T. Y., & Lam, T. K. T. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.013 · Cited by 91
Mayer, C. M., & Belsham, D. D. (2010) · Endocrinology · doi:10.1210/en.2009-0838 · Cited by 85
“Intracerebroventricular (icv) injection of insulin causes an anorectic response in mammals (5–7) and decreases hepatic glucose output (8).”
BackgroundKimura, K., Tanida, M., Nagata, N., Inaba, Y., Watanabe, H., Nagashimada, M., Ota, T., Asahara, S.-I., Kido, Y., Matsumoto, M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.032 · Cited by 84
“Various studies have indicated that central insulin action reduces hepatic glucose production (HGP), especially in rodents (Obici et al., 2002).”
BackgroundMethodInfluentialDeregulation of brain insulin signaling in Alzheimer’s disease
Chen, Y., Deng, Y., Zhang, B., & Gong, C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1408-x · Cited by 90
“Infusion of insulin into the CNS suppresses peripheral glucose production([47]) and decreases food intake and body weight([43-46]).”
BackgroundSelf-citationSteculorum, S. M., Solas, M., & Brüning, J. C. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.12.008 · Cited by 91
“In contrast to its anorexigenic effect, the antigluconeogenic effect of central insulin is not dependent of the melanocortin pathway [26].”
InfluentialCruciani‐Guglielmacci, C., Hervalet, A., Douared, L., Sanders, N. M., Levin, B. E., Ktorza, A., & Magnan, C. (2004) · Diabetologia · doi:10.1007/s00125-004-1569-2 · Cited by 92
“Elevated intracellular NEFA could also be responsible for the decrease of HGP [5], as a physiological way of reducing peripheral glucose availability.”
ResultInfluentialHigh-fat diet exposure induces IgG accumulation in hypothalamic microglia
Yi, C.-X., Tschöp, M. H., Woods, S. C., & Hofmann, S. M. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.009464 · Cited by 77
Peripheral nervous system insulin resistance in ob/ob mice
Grote, C. W., Groover, A. L., Ryals, J. M., Geiger, P. C., Feldman, E. L., & Wright, D. E. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-15 · Cited by 84
“Insulin promotes in vivo nerve regeneration [4,10,11], induces neurite outgrowth [12,13], maintains neuronal mitochondrial function [14,15], supports memory formation [16,17], and regulates hypothalamic metabolic control [18,19].”
BackgroundNovel neural pathways for metabolic effects of thyroid hormone
Fliers, E., Klieverik, L. P., & Kalsbeek, A. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.11.008 · Cited by 83
Central lactate metabolism regulates food intake
Lam, C. K. L., Chari, M., Wang, P. Y. T., & Lam, T. K. T. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90481.2008 · Cited by 81
Lam, C., Chari, M., Su, B., Cheung, G. W. C., Kokorovic, A., Yang, C. S., Wang, P. Y. T., Lai, T. Y. Y., & Lam, T. K. T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.087338 · Cited by 88
Faria, J. A., Kinote, A. P. B. D. M., Ignácio-Souza, L. M., de Araújo, T. M., Razolli, D. S., Doneda, D. L., Paschoal, L. B., Lellis‐Santos, C., Bertolini, G. L., Velloso, L. A., et al. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00094.2013 · Cited by 83
“The insulin-activated PI3K/Akt pathway in the hypothalamus has been shown to suppress hepatic glucose production irrespective of changes in peripheral insulin and other glucoregulatory hormones (24, 25).”
BackgroundHypothalamic AMPK as a Regulator of Energy Homeostasis
Huynh, M. K. Q., Kinyua, A. W., Yang, D. J., & Kim, K. W. (2016) · Neural Plasticity · doi:10.1155/2016/2754078 · Cited by 86
“In the central nervous system, insulin acts as a potent anorexigenic hormone [114].”
BackgroundInsulin action in the brain: Roles in energy and glucose homeostasis
Dodd, G. T., & Tiganis, T. (2017) · Journal of Neuroendocrinology · doi:10.1111/jne.12513 · Cited by 85
“All rights reserved obese, hyperphagic, and develop whole-body insulin resistance with dyslipidaemia and hyperinsulinemia, highlighting the importance of CNS insulin signalling in the coordination of energy and glucose homeostasis [144-146].”
BackgroundEffects of Intranasal Insulin on Hepatic Fat Accumulation and Energy Metabolism in Humans
Gancheva, S., Koliaki, C., Bierwagen, A., Nowotny, P., Heni, M., Fritsche, A., Häring, H.-U., Szendroedi, J., & Roden, M. (2015) · Diabetes · doi:10.2337/db14-0892 · Cited by 81
“comparable EGP and HIS after intranasal insulin contributes human data to the ongoing discussion on effects of brain insulin on peripheral, mainly hepatocyte and adipocyte metabolism observed in mice (1,10) but not in dogs (37).”
BackgroundInsulin transport into the brain
Gray, S. M., & Barrett, E. J. (2018) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00240.2017 · Cited by 83
“In rodents, hypothalamic IRs (75), downstream signaling through phosphoinositide 3-kinase (PI3K) (94, 95), and increased vagal nerve efferent activity (103) may mediate this process.”
BackgroundThe insulin resistant brain: impact on whole-body metabolism and body fat distribution
Heni, M. (2024) · Diabetologia · doi:10.1007/s00125-024-06104-9 · Cited by 89
“Another breakthrough was the discovery that brain insulin could modulate glucose metabolism via its influence on hepatic glucose production [7], presumably via the parasympathetic nervous system [8].”
Wallner-Liebmann, S. J., Koschutnig, K., Reishofer, G., Sorantin, E., Blaschitz, B., Kruschitz, R., Unterrainer, H., Gasser, R. N. A., Freytag, F., Bauer‐Denk, C., et al. (2010) · Obesity · doi:10.1038/oby.2010.26 · Cited by 90
“Recent evidence suggests that insulin may regulate appetite, body weight, and hepatic glucose production through direct binding to insulin receptors of the hypothalamus (12,13).”
BackgroundGrillo, C. A., Woodruff, J. L., Macht, V. A., & Reagan, L. P. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.04.012 · Cited by 74
Gut Hormones and Energy Balance, The Future for Obesity Therapy?
Meiliana, A., & Wijaya, A. (2009) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v1i3.99 · Cited by 79
Perrin, C., Knauf, C., & Burcelin, R. (2004) · Endocrinology · doi:10.1210/en.2004-0270 · Cited by 80
“Indeed, it has recently been shown that cerebral insulin signaling is required for the reduction of hepatic gluconeogenesis (41, 42), whereas leptin has the opposite effect, increasing the gluconeogenic flux (3).”
BackgroundAppetite- and Weight-Regulating Neuroendocrine Circuitry in Hypothalamic Obesity
Gan, H., Cerbone, M., & Dattani, M. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad033 · Cited by 82
“The discovery of insulin as a treatment for diabetes mellitus has been known for decades and is a longstanding historical landmark in the field of endocrinology (23), but its role in hypo-thalamic signaling and the regulation of appetite has only been recently deciphered (69-71).”
Functional properties of Claramine: A novel PTP1B inhibitor and insulin-mimetic compound
Qin, Z., Pandey, N. R., Zhou, X., Stewart, C. A., Hari, A., Huang, H., Stewart, A. F. R., Brunel, J. M., & Chen, H. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.040 · Cited by 80
Hu, F., Xu, Y., & Liu, F. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00121.2016 · Cited by 76
“Hypothalamic insulin signaling is known to be an important regulator of hepatic glucose production (HGP) in rodents (17, 51).”
BackgroundRictor/mTORC2 facilitates central regulation of energy and glucose homeostasis
Kocalis, H. E., Hagan, S. L., George, L., Turney, M. K., Siuta, M., Laryea, G. N., Morris, L. C., Muglia, L. J., Printz, R. L., Stanwood, G. D., et al. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.01.014 · Cited by 77
“Hypothalamic insulin signaling regulates peripheral glucose homeostasis and hepatic glucose production [7].”
BackgroundHistidine Augments the Suppression of Hepatic Glucose Production by Central Insulin Action
Kimura, K., Nakamura, Y., Inaba, Y., Matsumoto, M., Kido, Y., Asahara, S.-I., Matsuda, T., Watanabe, H., Maeda, A., Inagaki, F., et al. (2013) · Diabetes · doi:10.2337/db12-1701 · Cited by 72
“In addition, inhibition of phosphatidylinositol 3-kinase (PI3-K) in the insulin-signaling pathway in the hypothalamus inhibits the central insulin-dependent suppression of HGP (10).”
BackgroundInfluentialCentral and Opposing Effects of IGF-I and IGF-Binding Protein-3 on Systemic Insulin Action
Muzumdar, R. H., Ma, X., Fishman, S., Yang, X., Atzmon, G., Vuguin, P. M., Einstein, F. H., Hwang, D., Cohen, P., & Barzilai, N. (2006) · Diabetes · doi:10.2337/db06-0318 · Cited by 76
“Recently, novel metabolic effects of central nervous system insulin and leptin through the hypothalamus have been demonstrated, leading to alterations in both hepatic and peripheral glucose metabolism (10).”
BackgroundCNS-targets in control of energy and glucose homeostasis
Kleinridders, A., Könner, A. C., & Brüning, J. C. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.10.006 · Cited by 84
Hypothalamic Leucine Metabolism Regulates Liver Glucose Production
Su, Y., Lam, T. K. T., He, W., Pocai, A., Bryan, J., Aguilar‐Bryan, L., & Juárez, R. G. (2011) · Diabetes · doi:10.2337/db11-0857 · Cited by 82
“The activation of hypothalamic ATP-sensitive K channels (KATP channels) is critical for modulation of blood glucose levels and liver glucose metabolism (26) and for the metabolic effects of other nutrient-dependent signals (15,24,25).”
Background
Metadata
- Authors
- Obici, S., Zhang, B. B., Karkanias, G., & Rossetti, L.
- Affiliations
- Albert Einstein College of Medicine (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Rossetti, Luciano
- Venue
- Nature Medicine
- Published
- 2002-11-11
- Volume
- 8
- Issue
- 12
- Pages
- 1376-1382
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1964532167
- Cited by
- 904
- References
- 44
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 21 · 2023: 17 · 2022: 26 · 2021: 38 · 2020: 23 · 2019: 36 · 2018: 46 · 2017: 50 · 2016: 42 · 2015: 54 · 2014: 60 · 2013: 64 · 2012: 53
- FWCI
- 21.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-48321, DK20541, DK-45024)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- glucose production, insulin resistance, hyperinsulinemia, insulin mimetics, ATP-sensitive potassium channels, melanocortin receptors, type 2 diabetes, hyperglycemia, glucoregulation
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Glucose, Hypothalamus, Insulin, Male, Rats, Sprague-Dawley, Receptors, Corticotropin, Potassium Channel Blockers, Receptors, Melanocortin, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.